Assignee
SHANGHAI GENBASE BIOTECHNOLOGY CO LTD
CN·2 granted patents·6 pending applications·0 citations·filing 2016–2022
Top patents by PatentIndex Score
8 records- 0151US2022235142A1Anti-ceacam5 monoclonal antibody, preparation method thereof and use thereofSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 0246US12037409B2Antibody specifically bound to glycosylated CEACAM5SHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2021·Granted Jul 16, 2024·0 cites·5 claims
- 0346US2024123070A1Epitope peptide of ras g13d mutant and t cell receptor recognizing ras g13d mutantSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0445US2024000834A1Ras mutant epitope peptide and t cell receptor recognizing ras mutantSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0543US2024150455A1Anti-cldn6 antibody and use thereofSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0638US2021403552A1Anti-cldn18.2 antibody and uses thereofSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2018·Application pending·0 cites
- 0736US2022331363A1Bcma-targeted antibody and chimeric antigen receptorSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 0834US10934513B2Fully automated continuous cell culture systemSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2016·Granted Mar 2, 2021·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI GENBASE BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →